Molecular drivers of Parkinson’s disease have been revealed by scientists who also determined how they impact the functions of genes involved in the condition and the results may point to potential new treatments.

Join us to explore a novel method for high throughput solubility screening in drug discovery that is easy to use and insensitive to solvent or matrix interference.

Research has found that artificial intelligence in drug discovery will be worth $1,434 million by the end of 2024.

A new discovery on how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus.

On 5-6 November, ACC Liverpool hosted the ELRIG Drug Discovery event, which allowed R&D professionals to come together and discuss the latest industry developments.